Can a heart pill protect cancer Survivors' hearts?

NCT ID NCT05194111

Recruiting now Disease control Sponsor: Virginia Commonwealth University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests a drug called sacubitril-valsartan in young adult cancer survivors (diagnosed at or before age 39) who have early-stage heart failure (stage B) caused by past chemotherapy. The goal is to see if the drug is tolerable and can help control heart damage. About 53 participants will take the medication and be monitored for side effects and heart function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART DYSFUNCTION HEART FAILURE

Contacts and locations

Locations

Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.